tailieunhanh - HIV Medicine - part 10

Sự xuất hiện của thuốc kháng HIV-1 sau khi chính quyền trong chuyển dạ của nevirapine liều duy nhất là đánh giá thấp đáng kể. J lây nhiễm Dis năm 2005; 192: 16-23. Bản điện tử 2005 Jun 1. Tóm tắt: Lallement M, Jourdain G, Le Coeur S, et al. Chu sinh nevirapine liều duy nhất cộng với zidovudine tiêu chuẩn để ngăn chặn lây truyền HIV | 748 Drug Profiles 7. Johnson JA Li JF Morris L et al. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated. J Infect Dis 2005 192 16-23. Epub 2005 Jun 1. Abstract http id 15942889 8. Lallemant M Jourdain G Le Coeur S et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004 351 21728. http id 15247338 9. Martinez E Arnaiz JA Podzamczer D et al. Substitution of nevirapine efavirenz or abacavir for protease inhibitors in patients with HIV infection. NEJM 2003 349 1036-46. http id 12968087 10. Martinez E Blanco JL Arnaiz JA et al. Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS 2001 15 1261-1268. http id 11426070 11. Negredo E Molto J Burger D et al. Lopinavir ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients NEKA study . J Acquir Immune Defic Syndr 2005 38 47-52. Abstract http id 15608524 12. Parienti JJ Massari V Descamps D et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004 38 1311-6. http id 15127346 13. Sanne I Mommeja-Marin H Hinkle J et al. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. JID 2005 191 825-9. Abstract http id 15717255 14. Timmermans S Tempelman C Godfried MH et al. Nelfinavir and nevirapine side effects during pregnancy. AIDS 2005 19 795-9. Abstract http id 15867493 15. van Leth F Phanuphak P Ruxrungtham K et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine efavirenz or both drugs plus stavudine and lamivudine a randomised open-label trial the 2NN Study. .